Prospects for Pharmaceuticals: A forum with UK Trade and Investment (UKTI)
6 October 2011, London
The pharmaceutical sector has seen significant investment by Japanese companies in recent years. The industry as a whole has also been affected by more changes and developments than many others. There have been many regulatory, organisational and financial developments in addition to fairly radical shifts within the NHS, all of which have influenced the way things are managed. This talk by, and subsequent discussion with, four people involved at a senior level within UKTI and JETRO will focus on these changes and provide an exchange of views.
The four speakers at this session will be:
- Anil Vaidya (Chairman) – UKTI Life Science Investment Specialist – Introduction to UKTI and the trade activities in the life science sector
- Jon Mowles – UKTI Life Science Investment Specialist – An overview of the UK Life Sciences Sector
- Nigel Whittle – UKTI Research and Development Specialist – Japanese Pharma R &D Activities/Opportunities in the UK
- Jun Arima – JETRO Director General – JETRO’s Role and Activities
The level of UK-Japan exchange on medical and pharmaceutical matters is high and those with interests in the legal, investment, supply and support areas are likely to find the discussion very useful. It is likely to have wide relevance to many.
Location: The lecture is being arranged by the kind invitation of JETRO and will take place at their offices, Mid City Place, Holborn.
A sandwich lunch will be served from 12.00pm and the session will start promptly at 12.30pm. The event should be concluded by 2.00 pm. The cost of attendance will be £12 per head for members of the Japan Society and the JCCI and those introduced by JETRO and UKTI (£18 per head for non-members of any of them).
Support. The series of lectures are being attributed to the following companies which are committed to a five year programme of support for The Japan Society Schools Education and Outreach programmes: Itochu Europe Plc, Mitsubishi Corporation, Mitsui & Co Europe Plc, Sumitomo Corporation Europe Ltd, Astellas Pharma Inc, Canon Europe Ltd, Central Japan Railway Company, Chugai Pharmaceuticals, Daiichi Sankyo Co Ltd, Eisai Europe Ltd, Mitsubishi Europe Electric BV, PWC LLP, Swire Charitable Trust, Takeda Pharmaceutical Co Ltd and TEPCO.
Registration. The deadline for registration will be Wednesday 2nd November, after which no names will be accepted. Payment must accompany any application to attend and cheques should be made out to The Japan Society.
9 November 2011
JETRO London, Mid City Place, 71 High Holborn, London, WC1V 6QS
Tel:020 7828 6330
The Japan Society, UK Trade & Investment, JETRO